Jobs

PolyProx Therapeutics is a spin-out from Cambridge University, Department of Pharmacology based on exciting discoveries in the PROTACs/proteasome field.


The company will discover and develop a new class of drugs for the treatment of cancer, using novel engineered proteins that are able to selectively target tumour cells and trigger natural degradation machinery within the cell. This approach promises to address cancer targets that have proved intractable using current technologies, important in major diseases such as lung, colorectal and pancreatic cancers.

PolyProx Therapeutics is a spin-out from Cambridge University, Department of Pharmacology based on exciting discoveries in the PROTACs/proteasome field.


The company will discover and develop a new class of drugs for the treatment of cancer, using novel engineered proteins that are able to selectively target tumour cells and trigger natural degradation machinery within the cell. This approach promises to address cancer targets that have proved intractable using current technologies, important in major diseases such as lung, colorectal and pancreatic cancers.

Bruntwood SciTech owns and manages the largest portfolio of science and technology assets in the UK including prestigious locations like Manchester Science Park in Manchester, Alderley Park in Cheshire and Platform in Leeds.

Summary: Scientist I / II

PhoreMost® has developed a next-generation high-throughput screening platform called SITESEEKER® to identify the best new targets for future therapy and the mechanisms to drug them. Our technology is positioned to massively expand the diversity of novel therapeutics across multiple disease areas. We are looking for a talented scientist to join our functional genomic screening team and support our revolutionary discovery campaigns.

Translational Scientist


Location: Stratford, London


Salary: £43k - £53k + benefits

Contract: Permanent, full time


Please note that we will be shortlisting for interview on a rolling basis so early application is strongly encouraged to avoid any disappointment.


Are you a Translational scientist with broad experience across preclinical and early clinical development? Could you help us plan and implement pharmacology and toxicology packages to support submissions for vaccines, cell therapies or biologicals?


Why we need you

Johnson Matthey (JM) has an exciting opportunity for a Laboratory, Facilities & Quality Assistant to join our Health Sector. Operating from a state-of-the-art facility in Cambridge, we are world leaders in solid state science and crystallisation development. Our services currently include solid-form and physicochemical profiling, salt/polymorph, co-crystal screening and selection, and scale up of forms.


Key responsibilities:

The Vertebrate Genomics team are looking for a talented and motivated Project Leader to manage the NHGRI-EBI GWAS Catalog. The GWAS Catalog (www.ebi.ac.uk/gwas) is a high quality repository of all published genome wide association studies and is the leading international GWAS repository. It is considered the “go-to” resource for genetic evidence of associations between human genotypes and diseases or phenotypes.

Bruntwood SciTech owns and manages the largest portfolio of science and technology assets in the UK including prestigious locations like Manchester Science Park in Manchester, Alderley Park in Cheshire and Platform in Leeds.

With an expanding small molecule drug discovery portfolio, Artios Pharma is recruiting an experienced Director of Translation Science. This is an excellent opportunity to join a world class research team in a dynamic, fast paced Biotech company based south of Cambridge, UK. Artios is focused on identifying and developing cancer treatments by exploiting novel targets within the DNA damage response (DDR), a scientific area of high expectation following the success of PARP inhibitors in the clinic. The company is actively working on an exciting portfolio of unique DNA repair projects.

Start Date: Immediate preferred


Salary: Competitive compensation package including share options, subject to experience


Closing Date: 6th January 2020


About Healx

Pages